22 Feb 2017 | 1:45 AM
 

Welcure Drugs & Pharmaceuticals Ltd. Share Price Live (BSE)
0

BSE Code: 524661 | NSE Symbol:
3.80
-0.20
(-5.00 %)
20 Feb 2017 | 04:01 PM
Change company
  • Open (Rs)
    3.80
  • Prev. close (Rs.)
    4.00
  • High (Rs.)
    3.80
  • Low (Rs.)
    3.80
  • 52W H (Rs.)
    4.60
  • 52W L (Rs.)
    1.15
  • Volume (Rs.)
    72
  • MCap (Rs in Cr.)
    4.08
No Data Available
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
-1.31
Operating Margin (%)
-293.07
Gross Profit Margin (%)
-391.39
Net Profit Margin (%)
-112.78
Total Debt/Equity
0.00
Dividend payout Ratio (Net Profit)
0.00
Earning Retention Ratio
0.00

News

17 Feb 2017 - 13:55:00-Drug major Dr Reddy's Laboratories said there are no claims against the company for monetary dam...
17 Feb 2017 - 13:49:00-Pharma major Cadila Healthcare Ltd on Friday said that Zydus Cadila has received final approval from...
17 Feb 2017 - 09:22:00-Biocon Ltd. has said that the U.S...
16 Feb 2017 - 17:01:00-Drug firm Lupin has received approval from the US health regulator for generic Hydrocodone Bitartrat...

Announcements

07-Jan-2017
Welcure Drugs & - Standalone Financial Results Limited Review Report for December 31 2016
06-Jan-2017
Welcure Drugs & - Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations 2015 for Quarter ended Decembe
05-Jan-2017
Welcure Drugs & - Shareholding for the Period Ended December 31 2016
31-Dec-2016
Welcure Drugs & - Board Meeting Intimation for Results
18-Oct-2016
Welcure Drugs & - Limited Review Report for September 30 2016

Religare Research

21 Feb 2017 | 11:59 AM
Agri Fundamental report
21 Feb 2017 | 11:58 AM
Agri Technical report
21 Feb 2017 | 11:09 AM
SML Isuzu reported in-line Q3FY17 numbers, wherein Net sales increased by 18.3% to Rs. 228.1 Cr and ...
21 Feb 2017 | 10:01 AM
• Gold marginally down at MCX in quiet trade as U.S. holiday mutes action • U.S. natural gas slides ...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
No Data Available

Shareholding Pattern

      
Promotors17.81%
Mutual Funds/UTI0.00%
FI/Banks0.00%
Insurance0.00%
FII0.00%
Government0.00%
Others14.51%

Peer Group

Company Intraday Graph
 Merck Ltd.
1,131.05(5.98)
3302
 Kovai Medical Center and Hospital Ltd.
1,115.00(1.39)
11816
 AstraZeneca Pharma India Ltd.
928.00(0.12)
3274
 Neuland Laboratories Ltd.
918.00(1.95)
3578

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Welcure Drugs & Pharmaceuticals Ltd.0.21-0.041.52
NIFTY(S&P CNX)516.35978.75278.70
BSE SENSEX1,644.252,996.45776.05
BSE 500757.711,515.76573.15

Corporate Details

Key Personal
M L Bhateja
Director & CFO
Rashi Aggarwal
Director & Company Secretary
Sudhir Chandra
Managing Director
Key Address
Registered Office
B- 9 &10 Laxmi Towers II LSC C Block Saraswati Vihar,New Delhi,Delhi

Tel:011-27011428, Fax:011-27023256

investor.welcure@gmail.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :C-13 Pannalal Silk Mill Compound LBS Marg Bhandup (West)

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Welcure Drugs & Pharmaceuticals Ltd. that will help you decide whether to buy, sell or hold Welcure Drugs & Pharmaceuticals Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Welcure Drugs & Pharmaceuticals Ltd.